Chempartner Pharmatech Co., Ltd. announced a private placement of A shares for gross proceeds of not more than CNY 300,000,000 on May 8, 2022. The issue price shall not be lower than 80% of the average stock trading price of the 20 trading days prior to the pricing benchmark date. The transaction will include participation from not more than 35 investors.

The shares issued will be subject to restriction period of 6 months from closing. The transaction has been approved at the 18th meeting of 5th session of board of directors, subject to 2021 annual general meeting.